top of page
Accurate accounting of caplacizumab cost effectiveness
Goshua G, Prasad V, Lee AI, Bendapudi PK.
The Lancet Haematology
May
2021
Intermediate-dose anticoagulation, aspirin, and in- hospital mortality in COVID-19: a propensity score-matched analysis
Goshua G (co-first), Meizlish ML, Liu Y, Fine R, Amin K, Chang E, Defilippo NA, Keating C, Mankbadi M, McManus D, Wang SY, Price C, Bona RD, Ochoa Chaar CI, Chun HJ, Pine AB, Rinder HM, Siner JM, Neuberg DS, Owusu KA, Lee AI.
American Journal of Hematology
April
2021
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang C, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz CS, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun H
Blood Advances
March
2021
Fever, pancytopenia, and elevated D-dimer in a 95-year old woman with ehrlichiosis: a case report
Radcliffe C, Tsay C, Glerum K, Liao J, Goshua G, Kerins G
BMC Geriatrics
March
2021
Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Goshua G, Sinha P, Hendrickon JE, Tormey C, Bendapudi PK, Lee AI
Blood
February
2021
Harmonizing hypercoagulable heterogeneity: baseline VTE risk in COVID-19
Goshua G and Lee AI
Research and Practice in Thrombosis and Haemostasis
January
2021
Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19
Pine AB, Meizlish ML, Goshua G (co-first), Chang C, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan J, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun H
Pulmonary Circulation
November
2020
Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes
Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, McManus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M
Chest
October
2020
Featured Publications (5)
All Selected Publications
Intermediate-dose anticoagulation, aspirin, and in- hospital mortality in COVID-19: a propensity score-matched analysis
Goshua G (co-first), Meizlish ML, Liu Y, Fine R, Amin K, Chang E, Defilippo NA, Keating C, Mankbadi M, McManus D, Wang SY, Price C, Bona RD, Ochoa Chaar CI, Chun HJ, Pine AB, Rinder HM, Siner JM, Neuberg DS, Owusu KA, Lee AI.
American Journal of Hematology
2021
April
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang C, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz CS, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun H
Blood Advances
2021
March
Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19
Pine AB, Meizlish ML, Goshua G (co-first), Chang C, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan J, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun H
Pulmonary Circulation
2020
November
Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes
Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, McManus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M
Chest
2020
October
Prophylactic weekly efanesoctocog alfa versus standard-care factor VIII in people living with severe hemophilia A: a cost-effectiveness analysis
Ito S, Potnis KC, Harvey JP, Sra M, Bewersdorf JP, Bona RD, Krumholz HM, Cuker A, Pandya A, Goshua G.
Annals of Internal Medicine
2025
June
FEATURED
Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening
Ito S, Xicola RM, Sra M, Potnis KC, Singh V, Gershkovich P, Stites E, Gibson J, Krumholz HM, Llor X, Goshua G
Clinical Gastroenterology & Hepatology
2025
April
FEATURED
Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women
Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
FEATURED
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz H, Lee AI, Cuker A, Goshua G.
Blood
2025
January
FEATURED
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource
Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G
American Journal of Hematology
2024
April
FEATURED
RECOGNITIONS:
Gap: Supporting the mission of the 501(c)(3) Alloantibody Exchange www.alloantibody.org. 2022 ASH Press Program Selection.
PRACTICAL IMPACT:
Publications
bottom of page